This is particularly common in Parkinson s disease and other neurodegenerative dis- orders. For management of this problem, the reader is referred to the recommendations of a 2017 consensus 2. Patients with prevalent and frequent falls, advanced cog- nitive impairment, and multiple comorbidities may be at risk of adverse outcomes with intensive BP lowering, especially when they require multiple BP-lowering medi- cations. Older persons in this category typically reside in nursing homes and assisting living facilities, are unable to live independently in the community, and have not been represented in RCTs. 10.3.2. Children and Adolescents Pediatric guidelines are available from other The 2011 report updates the 2004 report for publications through 2008 (antihypertensive medi- cation trials, normative data on pediatric BP) but is otherwise unchanged. In the 2011 guideline,S10.3.2-3 BP was stratified into normal, prehypertension (90th percentile to 95th percentile), stage 1 hypertension (95th percentile to >99th percentile), and stage 2 hypertension (above stage 1) by using age-, sex-, and height-based tables beginning at 1 year of age, which were based on the distribution of BP in >60000 healthy children in various population-based studies.S10.3.2-1 These definitions were designed to be analogous to definitions in the extant JNC 7 report; for older adolescents ( 14 years), the JNC 7 thresh- olds generally apply.S10.3.2-4 Treatment recommendations are based on hypertension severity, published short-term clinical trials of antihypertensive treatment, age, coexisting CVD risk factors, and risk stratification by presence of LVH on echo- cardiogram. The treatment goal is to achieve BP <90th per- centile. New tables for ambulatory BP distribution in children have been developed. A classification of BP that is based on these ambulatory BP results has been proposed.S10.3.2-5,S10.3.2-6 A new pediatric BP guideline was published in late 2017.S10.3.2-7 11. Other Considerations 11.1. 